Quantitative Multiplexed Analysis of ErbB Family Co-expression for Primary Breast Cancer Prognosis in a Large Retrospective Cohort

Autor Giltnane, Jennifer M., Moeder, Christopher B., Camp, Robert L., Rimm, David L.
Vydáno 2009

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer

Autor Nadler, Yasmine, Camp, Robert L, Giltnane, Jennifer M, Moeder, Christopher, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Vydáno 2008

The ERα coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium

Autor Rokicki, Jerzy, Das, Partha M, Giltnane, Jennifer M, Wansbury, Olivia, Rimm, David L, Howard, Beatrice A, Jones, Frank E
Vydáno 2010

Analytic Variability in Immunohistochemistry Biomarker Studies

Autor Anagnostou, Valsamo K., Welsh, Allison W., Giltnane, Jennifer M., Siddiqui, Summar, Liceaga, Camil, Gustavson, Mark, Syrigos, Konstantinos N., Reiter, Jill L., Rimm, David L.
Vydáno 2010

PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin

Autor Ondrejka, Sarah L., Jegalian, Armin G., Kim, Annette S., Chabot-Richards, Devon S., Giltnane, Jennifer, Czuchlewski, David R., Shetty, Shashirekha, Sekeres, Mikkael A, Yenamandra, Ashwini, Head, David, Jagasia, Madan, Hsi, Eric D.
Vydáno v Haematologica (2014)

Single-cell dynamics determines response to CDK4/6 inhibition in triple negative breast cancer

Autor Asghar, Uzma S., Barr, Alexis R., Cutts, Ros, Beaney, Matthew, Babina, Irina, Sampath, Deepak, Giltnane, Jennifer, Lacap, Jennifer Arca, Crocker, Lisa, Young, Amy, Pearson, Alex, Herrera-Abreu, Maria Teresa, Bakal, Chris, Turner, Nicholas C.
Vydáno v Clin Cancer Res (2017)

Kinome wide functional screen identifies role of Polo-like kinase 1 (PLK1) in hormone-independent, ER-positive breast cancer

Autor Bhola, Neil, Jansen, Valerie M., Bafna, Sangeeta, Giltnane, Jennifer M., Balko, Justin M., Estrada, Mónica V., Meszoely, Ingrid, Mayer, Ingrid, Abramson, Vandana, Ye, Fei, Sanders, Melinda, Dugger, Teresa C., Van Allen, Eliezer, Arteaga, Carlos L.
Vydáno v Cancer Res (2014)

NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma

Autor Hegde, Ganapati V, de la Cruz, Cecile, Giltnane, Jennifer M, Crocker, Lisa, Venkatanarayan, Avinashnarayan, Schaefer, Gabriele, Dunlap, Debra, Hoeck, Joerg D, Piskol, Robert, Gnad, Florian, Modrusan, Zora, de Sauvage, Frederic J, Siebel, Christian W, Jackson, Erica L
Vydáno v eLife (2019)

MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells through regulation of mitochondrial oxidative phosphorylation

Autor Lee, Kyung-min, Giltnane, Jennifer M., Balko, Justin M., Schwarz, Luis J., Guerrero-Zotano, Angel L., Hutchinson, Katherine E., Nixon, Mellissa J., Estrada, Mónica V., Sánchez, Violeta, Sanders, Melinda E., Lee, Taekyu, Gómez, Henry, Lluch, Ana, Pérez-Fidalgo, J. Alejandro, Wolf, Melissa Magdalene, Andrejeva, Gabriela, Rathmell, Jeffrey C., Fesik, Stephen W., Arteaga, Carlos L.
Vydáno v Cell Metab (2017)

Triple negative breast cancers with amplification of JAK2 at the 9p24 loci demonstrate JAK2-specific dependence

Autor Balko, Justin M., Schwarz, Luis J., Cook, Rebecca S., Estrada, Monica V., Giltnane, Jennifer M., Sanders, Melinda E., Sánchez, Violeta, Dean, Phillip T., Wang, Kai, Combs, Susan E., Hicks, Donna, Pinto, Joseph A., Landis, Melissa D., Chang, Jenny C., Doimi, Franco D., Gómez, Henry, Rimm, David L., Yelensky, Roman, Miller, Vincent A., Stephens, Phillip J., Arteaga, Carlos L.
Vydáno v Sci Transl Med (2016)

Association of FGFR1 with ERα maintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer

Autor Formisano, Luigi, Stauffer, Kimberly M., Young, Christian D., Bhola, Neil E., Guerrero, Angel L., Jansen, Valerie M., Estrada, Mónica Valeria, Hutchinson, Katherine E., Giltnane, Jennifer M., Schwarz, Luis J., Lu, Yao, Balko, Justin M., Deas, Olivier, Cairo, Stefano, Judde, Jean-Gabriel, Mayer, Ingrid A., Sanders, Melinda E., Dugger, Teresa C., Bianco, Roberto, Stricker, Thomas P., Arteaga, Carlos L.
Vydáno v Clin Cancer Res (2017)

ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors

Autor Guerrero-Zotano, Angel L., Stricker, Thomas P., Formisano, Luigi, Hutchinson, Katherine E., Stover, Daniel G., Lee, Kyung-min, Schwarz, Luis J., Giltnane, Jennifer M., Estrada, Valeria M., Jansen, Valerie M., Servetto, Alberto, Gavilá, Joaquín, Perez-Fidalgo, J. Alejandro, Lluch, Ana, Llombart, Antonio, Bayar, Mohamed A., Michiels, Stefan, André, Fabrice, Arnedos, Mónica, Guillem, Vicente, Ruiz, Amparo, Arteaga, Carlos L.
Vydáno v Clin Cancer Res (2018)

Correction: ER(+) Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Autor Guerrero-Zotano, Angel L., Stricker, Thomas P., Formisano, Luigi, Hutchinson, Katherine E., Stover, Daniel G., Lee, Kyung-Min, Schwarz, Luis J., Giltnane, Jennifer M., Estrada, Monica V., Jansen, Valerie M., Servetto, Alberto, Gavilá, Joaquín, Perez-Fidalgo, J. Alejandro, Lluch, Ana, Llombart-Cussac, Antonio, Bayar, Mohamed Amine, Michiels, Stefan, André, Fabrice, Arnedos, Mόnica, Guillem, Vicente, Ruiz-Simon, Amparo, Arteaga, Carlos L.
Vydáno v Clin Cancer Res (2019)

RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint...

Autor Loi, Sherene, Dushyanthen, Sathana, Beavis, Paul A, Salgado, Roberto, Denkert, Carsten, Savas, Peter, Combs, Susan, Rimm, David L., Giltnane, Jennifer M., Estrada, Monica V., Sánchez, Violeta, Sanders, Melinda E., Cook, Rebecca S., Pilkinton, Mark A., Mallal, Simon A., Wang, Kai, Miller, Vincent A., Stephens, Phil J., Yelensky, Roman, Doimi, Franco D., Gómez, Henry, Ryzhov, Sergey V., Darcy, Phillip K., Arteaga, Carlos L., Balko, Justin M.
Vydáno v Clin Cancer Res (2015)

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

Autor Balko, Justin M., Giltnane, Jennifer M., Wang, Kai, Schwarz, Luis J., Young, Christian D., Cook, Rebecca S., Owens, Phillip, Sanders, Melinda E., Kuba, Maria G., Sánchez, Violeta, Kurupi, Richard, Moore, Preston D., Pinto, Joseph A., Doimi, Franco D., Gómez, Henry, Horiuchi, Dai, Goga, Andrei, Lehmann, Brian D., Bauer, Joshua A., Pietenpol, Jennifer A., Ross, Jeffrey S., Palmer, Gary A., Yelensky, Roman, Cronin, Maureen, Miller, Vincent A., Stephens, Phillip J., Arteaga, Carlos L.
Vydáno 2013

Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor positive breast cancer

Autor Jeselsohn, Rinath, Yelensky, Roman, Buchwalter, Gilles, Frampton, Garrett, Meric-Bernstam, Funda, Gonzalez-Angulo, Ana Maria, Ferrer-Lozano, Jaime, Perez-Fidalgo, Jose A., Cristofanilli, Massimo, Gómez, Henry, Arteaga, Carlos L., Giltnane, Jennifer, Balko, Justin M., Cronin, Maureen T, Jarosz, Mirna, Sun, James, Hawryluk, Matthew, Lipson, Doron, Otto, Geoff, Ross, Jeffrey S, Dvir, Addie, Soussan-Gutman, Lior, Wolf, Ido, Rubinek, Tamar, Gilmore, Lauren, Schnitt, Stuart, Come, Steven E., Pusztai, Lajos, Stephens, Philip, Brown, Myles, Miller, Vincent A.
Vydáno 2014

TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Autor Mariathasan, Sanjeev, Turley, Shannon J., Nickles, Dorothee, Castiglioni, Alessandra, Yuen, Kobe, Wang, Yulei, Kadel, Edward E., Koeppen, Hartmut, Astarita, Jillian L., Cubas, Rafael, Jhunjhunwala, Suchit, Banchereau, Romain, Yang, Yagai, Guan, Yinghui, Chalouni, Cecile, Ziai, James, Şenbabaoğlu, Yasin, Santoro, Stephen, Sheinson, Daniel, Hung, Jeffrey, Giltnane, Jennifer M., Pierce, Andrew K., Mesh, Kathryn, Lianoglou, Steve, Riegler, Johannes, Carano, Richard A. D., Eriksson, Pontus, Hoglund, Mattias, Somarriba, Loan, Halligan, Daniel L., van der Heijden, Michiel, Loriot, Yohann, Rosenberg, Jonathan E., Fong, Lawrence, Mellman, Ira, Chen, Daniel S., Green, Marjorie, Derleth, Christina, Fine, Gregg D., Hegde, Priti S., Bourgon, Richard, Powles, Thomas
Vydáno v Nature (2018)

The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Autor Joseph, James D, Darimont, Beatrice, Zhou, Wei, Arrazate, Alfonso, Young, Amy, Ingalla, Ellen, Walter, Kimberly, Blake, Robert A, Nonomiya, Jim, Guan, Zhengyu, Kategaya, Lorna, Govek, Steven P, Lai, Andiliy G, Kahraman, Mehmet, Brigham, Dan, Sensintaffar, John, Lu, Nhin, Shao, Gang, Qian, Jing, Grillot, Kate, Moon, Michael, Prudente, Rene, Bischoff, Eric, Lee, Kyoung-Jin, Bonnefous, Celine, Douglas, Karensa L, Julien, Jackaline D, Nagasawa, Johnny Y, Aparicio, Anna, Kaufman, Josh, Haley, Benjamin, Giltnane, Jennifer M, Wertz, Ingrid E, Lackner, Mark R, Nannini, Michelle A, Sampath, Deepak, Schwarz, Luis, Manning, Henry Charles, Tantawy, Mohammed Noor, Arteaga, Carlos L, Heyman, Richard A, Rix, Peter J, Friedman, Lori, Smith, Nicholas D, Metcalfe, Ciara, Hager, Jeffrey H
Vydáno v eLife (2016)

Correction: The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer

Autor Joseph, James D, Darimont, Beatrice, Zhou, Wei, Arrazate, Alfonso, Young, Amy, Ingalla, Ellen, Walter, Kimberly, Blake, Robert A, Nonomiya, Jim, Guan, Zhengyu, Kategaya, Lorna, Govek, Steven P, Lai, Andiliy G, Kahraman, Mehmet, Brigham, Dan, Sensintaffar, John, Lu, Nhin, Shao, Gang, Qian, Jing, Grillot, Kate, Moon, Michael, Prudente, Rene, Bischoff, Eric, Lee, Kyoung-Jin, Bonnefous, Celine, Douglas, Karensa L, Julien, Jackaline D, Nagasawa, Johnny Y, Aparicio, Anna, Kaufman, Josh, Haley, Benjamin, Giltnane, Jennifer M, Wertz, Ingrid E, Lackner, Mark R, Nannini, Michelle A, Sampath, Deepak, Schwarz, Luis, Manning, Henry Charles, Tantawy, Mohammed Noor, Arteaga, Carlos L, Heyman, Richard A, Rix, Peter J, Friedman, Lori, Smith, Nicholas D, Metcalfe, Ciara, Hager, Jeffrey H
Vydáno v eLife (2019)

Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarke...

Autor Hendry, Shona, Salgado, Roberto, Gevaert, Thomas, Russell, Prudence A., John, Tom, Thapa, Bibhusal, Christie, Michael, van de Vijver, Koen, Estrada, M. Valeria, Gonzalez-Ericsson, Paula I., Sanders, Melinda, Solomon, Benjamin, Solinas, Cinzia, Van den Eynden, Gert GGM, Allory, Yves, Preusser, Matthias, Hainfellner, Johannes, Pruneri, Giancarlo, Vingiani, Andrea, Demaria, Sandra, Symmans, Fraser, Nuciforo, Paolo, Comerma, Laura, Thompson, E. Aubrey, Lakhani, Sunil, Kim, Seong-Rim, Schnitt, Stuart, Colpaert, Cecile, Sotiriou, Christos, Scherer, Stefan J., Ignatiadis, Michail, Badve, Sunil, Pierce, Robert H., Viale, Giuseppe, Sirtaine, Nicolas, Penault-Llorca, Frederique, Sugie, Tomohagu, Fineberg, Susan, Paik, Soonmyung, Srinivasan, Ashok, Richardson, Andrea, Wang, Yihong, Chmielik, Ewa, Brock, Jane, Johnson, Douglas B., Balko, Justin, Wienert, Stephan, Bossuyt, Veerle, Michiels, Stefan, Ternes, Nils, Burchardi, Nicole, Luen, Stephen J., Savas, Peter, Klauschen, Frederick, Watson, Peter H., Nelson, Brad H., Criscitiello, Carmen, O’Toole, Sandra, Larsimont, Denis, de Wind, Roland, Curigliano, Giuseppe, André, Fabrice, Lacroix-Triki, Magali, van de Vijver, Mark, Rojo, Federico, Floris, Giuseppe, Bedri, Shahinaz, Sparano, Joseph, Rimm, David, Nielsen, Torsten, Kos, Zuzana, Hewitt, Stephen, Singh, Baljit, Farshid, Gelareh, Loibl, Sibylle, Allison, Kimberly H., Tung, Nadine, Adams, Sylvia, Willard-Gallo, Karen, Horlings, Hugo M., Gandhi, Leena, Moreira, Andre, Hirsch, Fred, Dieci, Maria Vittoria, Urbanowicz, Maria, Brcic, Iva, Korski, Konstanty, Gaire, Fabien, Koeppen, Hartmut, Lo, Amy, Giltnane, Jennifer, Ziai, James, Rebelatto, Marlon C., Steele, Keith E., Zha, Jiping, Emancipator, Kenneth, Juco, Jonathan W., Denkert, Carsten, Reis-Filho, Jorge, Loi, Sherene, Fox, Stephen B.
Vydáno v Adv Anat Pathol (2017)